Platelet Rich Plasma (PRP) Market By Product Type (Pure Platelet Rich Plasma, Pure Platelet Rich Fibrin, Leukocyte-Platelet Rich Fibrin, Others), By Application (General Surgery, Neurosurgery, Cardiac Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Others), and Geography  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

The global platelet rich plasma (PRP) market size was estimated at USD 474.1 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.2% from 2022 to 2028. Platelet Rich Plasma (PRP) Market is a permanent solution for various conditions such as ligament/tendon sprains, arthritis, and tears. Platelet rich plasma (PRP) therapy is usually done by utilizing the body’s natural healing process. In this therapy, the concentration of platelets are injected into the damaged tendons, joints and ligaments in order to accelerate healing that anticipates tissue repair. The platelets are considered to be rich in growth and healing factors. The Platelet rich plasma (PRP) injections are used in the treatment of various conditions such as shoulder pain and instability, lumbar spine disc pain, knee sprains and instability, hamstring and hip strains, ankle sprains, knee, hip, and other joint osteoarthritis among others. The major variables that are considerably boosting the target market's growth are Some of the key determinants driving the platelet rich plasma market globally are an increase in the number of orthopaedic surgeries and sports injuries, an increase in the number of cosmetic surgeries, growing awareness about platelet rich plasma treatment in dental health, approval of new devices and the discovery of new application areas, rising geriatric population, and a surge in awareness among the global population. The significant volatility in the price of platelet rich plasma therapy, on the other hand, as well as inadequate reimbursement policies, would stifle the platelet rich plasma market's growth.

Platelet Rich Plasma Prp Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Platelet Rich Plasma (PRP) Market Dynamics

Increase in the geriatric population along with increase in health issues are the key factors attributing the growth of Platelet rich plasma (PRP) market. The rising applications of platelet rich plasma (PRP) in various areas anticipated to fuel the growth of the market. The soaring use of PRP application in the cosmetic surgeries is boosting the growth of the market. The successful application of PRP in the orthopedic disorders such as Achilles tendinopathy, knee osteoarthritis, rotator cuff tears, and lateral epicondylitis has enhanced the growth of the Platelet rich plasma market. Growing incidence of sport injuries is adding scope for further growth in the market. However, the high risk of contamination owing to improper storage is hampering the growth of the market. The difficulty in quality control of test results is hindering the growth of the Platelet rich plasma market.

Key Features of the Reports

  • The elderly care services market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Platelet Rich Plasma Prp Market Segmentation

By Product Type
  • Pure Platelet Rich Plasma
  • Pure Platelet Rich Fibrin
  • Leukocyte-Platelet Rich Fibrin
  • Others
By Application
  • General Surgery
  • Neurosurgery
  • Cardiac Surgery
  • Orthopedic Surgery
  • Others
by End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Frequently Asked Questions

The platelet-rich plasma market is projected to expand at a CAGR of 5.7% during the forecast period  

Abbott Laboratories (U.S),Siemens Healthcare Inc. (Germany), Thermo Fischer Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S), Biocept, Inc (U.S.)

North America is the fastest-growing region for platelet rich plasma market  

  • Hoffman-La Roche Ltd. (Switzerland)
  • Abbott Laboratories (U.S)
  • Siemens Healthcare Inc. (Germany)
  • Thermo Fischer Scientific, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S)
  • Biocept, Inc (U.S.)
  • Illumina, Inc., (U.S)
  • AstraZeneca plc, (U.K)
  • Epigenomics AG (Germany)
  • Quest Diagnostics Incorporated (U.S.)
  • Myriad Genetics, Inc.(U.S.